27.07.2011 • NewsQ2 2011GlaxoSmithKline (GSK)GSK

GlaxoSmithKline Swings to Profit In Q2

GlaxoSmithKline reported second-quarter profit attributable to shareholders of £1.11 billion versus a loss of £304 million  last year. Pre-tax profit for the period was £1.59 billion pounds, as against a loss of £97 million a year earlier.

On a per share basis, earnings for the recent quarter were 21.6 pence compared with a 5.9 pence loss in the prior-year period. Earnings per share before major restructuring for the quarter was 25.0 pence versus 2.6 pence in the 2010 second quarter. Excluding legal charges, earnings per share declined 11% in CER terms and 10% in sterling terms.

Turnover for the three months ended June 30 totaled £6.72 billion compared with £7.025 billion in the previous year.

The board declared a second interim dividend of 16 pence per share, making 32 pence for the half-year. The equivalent interim dividend receivable by ADR holders is 52.1088 cents per ADS based on an exchange rate of £1/$1.6284.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.